Hepatitis C Virus NS4a,NS4b (HCV NS4a,NS4b) (AA 1658-1863) Peptide
HCV NS4a,NS4b
Reactivity: Hepatitis C Virus (HCV)
Host: Escherichia coli (E. coli)
ELISA, WB
-
- Target See all HCV NS4 A+b (HCV NS4a,NS4b) products
- HCV NS4 A+b (HCV NS4a,NS4b) (Hepatitis C Virus NS4a,NS4b (HCV NS4a,NS4b))
- Peptide Type
- Recombinant
- Protein Region
- AA 1658-1863
- Origin
- Hepatitis C Virus (HCV)
- Source
- Escherichia coli (E. coli)
- Application
- ELISA, Western Blotting (WB)
- Characteristics
-
Hepatitis C Virus NS4 a+b recombinant protein
Expression System: E.coli - Purification
- Proprietary chromatographic technique
- Purity
- > 95 % pure
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Buffer
- 20 mM tris-HCl, pH 8, with 8 M urea and 10 mM B-ME.
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- RT/-20 °C
-
- Target
- HCV NS4 A+b (HCV NS4a,NS4b) (Hepatitis C Virus NS4a,NS4b (HCV NS4a,NS4b))
- Target Type
- Viral Protein
- Background
-
HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).
Alternative Names: Hep C protein, HCV protein, HCV NS4 a + b protein, HCV Recombinant protein, Hepatitis C protein - Molecular Weight
- 19 kDa
-
You are here:
